BORSI, ENRICA
 Distribuzione geografica
Continente #
NA - Nord America 1.621
EU - Europa 1.187
AS - Asia 337
AF - Africa 100
Totale 3.245
Nazione #
US - Stati Uniti d'America 1.614
GB - Regno Unito 305
IT - Italia 226
SE - Svezia 189
DE - Germania 158
CN - Cina 148
VN - Vietnam 99
IE - Irlanda 69
IN - India 66
RU - Federazione Russa 48
FR - Francia 46
TG - Togo 36
ZA - Sudafrica 27
EE - Estonia 26
BE - Belgio 25
CH - Svizzera 22
CI - Costa d'Avorio 22
FI - Finlandia 22
UA - Ucraina 17
NG - Nigeria 15
AT - Austria 11
IR - Iran 8
JO - Giordania 8
CA - Canada 7
RO - Romania 5
ES - Italia 4
NL - Olanda 4
PH - Filippine 4
PT - Portogallo 2
RS - Serbia 2
CZ - Repubblica Ceca 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
SG - Singapore 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 3.245
Città #
Southend 284
Chandler 262
Fairfield 204
Ann Arbor 108
Ashburn 101
Bologna 88
Wilmington 87
Woodbridge 83
Houston 78
Seattle 78
Princeton 70
Dublin 69
Cambridge 66
Dong Ket 45
Lomé 36
Boydton 32
Nanjing 31
Westminster 28
Padova 26
Brussels 25
Bremen 24
Berlin 23
Abidjan 22
Helsinki 21
Salsomaggiore Terme 20
Redmond 19
Bern 17
Jinan 16
Turin 15
Abeokuta 14
Saint Petersburg 14
Chicago 13
Medford 13
Shenyang 13
Beijing 12
Hebei 11
Nanchang 11
Redwood City 11
Vienna 11
Milan 10
Falls Church 9
Amman 8
Florence 8
Changsha 7
Norwalk 7
San Diego 7
Hangzhou 6
Jiaxing 6
Kuban 6
Toronto 6
Paris 5
Reggio Emilia 5
Tianjin 5
Zhengzhou 5
Ardabil 4
Boardman 4
Coimbatore 4
Como 4
Dearborn 4
Des Moines 4
Hanover 4
Monmouth Junction 4
Olalla 4
Romainville 4
San Lazzaro Di Savena 4
Geneva 3
Groningen 3
Haikou 3
Lanzhou 3
Las Vegas 3
Mülheim 3
San Francisco 3
Stilo 3
Taizhou 3
Bari 2
Belgrade 2
Frankfurt Am Main 2
Fremont 2
Henderson 2
Hockenheim 2
Lausanne 2
Leawood 2
Los Angeles 2
Modena 2
Ningbo 2
Wuhan 2
Ahmedabad 1
Andover 1
Brooklyn 1
Budapest 1
Buffalo 1
Busseto 1
Cagliari 1
Chiswick 1
Crespina 1
Den Haag 1
Falkenstein 1
Frankfurt am Main 1
Genova 1
Glasgow 1
Totale 2.310
Nome #
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 176
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells 146
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD) 141
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma. 123
Treatment optimization for Multiple Myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in an in vitro and ex-vivo model 122
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 119
Cap dependent translation contributes to resistance of myeloma cells to bortezomib 116
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor 110
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 108
Genomic characterization of the putative myeloma stem cells clone reveals alterations possibly correlated with the origin of disease. 107
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53 104
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment 103
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 103
Analysis of mismatch repair gene mutations in Turkish HNPCC patients 101
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia 100
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 99
Inter-Cell Networking Profiling Enables Comprehensive Characterization of Immune-Mediated Activity of Anti-CD38 Therapy through Ex-Vivo Analysis of Multiple Myeloma Patients 99
SIRT regulates the molecular interaction between c-MYC and HIF-1 alpha in multiple myeloma 91
Relative role ofAPCandMUTYHmutations in the pathogenesis of familial adenomatous polyposis 89
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 88
High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53 84
Impact Of p53 Impaired Function On Outcomes Of Multiple Myeloma Patients Carrying Deleted TP53 and/Or Amplified MDM4 84
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma 84
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 83
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma 83
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA 80
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 78
AIRTUM numbers: 200,000 young Italians live with cancer 69
VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma 65
[Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients]. 61
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 58
Italian cancer figures, report 2012: Cancer in children and adolescents. 52
[Italian cancer figures, report 2011: Survival of cancer patients in Italy]. 48
Loss of nuclear beta catenin, following chibby enforced expression, activates endoplasmic reticulum stress in cells expressing the BCR-ABL1 fusion gene of chronic myeloid leukemia 45
A Methodologically Updated De-Novo Extraction of Copy Number Signatures in Multiple Myeloma: Clinical Significance and Putative Aetiologies 42
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 36
BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles 33
OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival 22
Totale 3.352
Categoria #
all - tutte 6.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019125 0 0 1 7 4 28 5 4 13 25 6 32
2019/2020780 133 28 0 43 74 57 98 106 113 48 33 47
2020/2021398 74 23 6 9 13 16 6 20 60 13 11 147
2021/2022742 32 36 41 48 65 41 20 41 42 103 121 152
2022/20231.080 80 133 43 153 79 83 34 56 158 60 111 90
2023/2024102 38 45 19 0 0 0 0 0 0 0 0 0
Totale 3.352